Stock chart
Ticker: ZIOP Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
2023-09-05 2023-09-01 PS Planned sale

Boyle Kevin S. Sr.

Chief Executive Officer

Executive Director
68,014 -7.9%
0.14
9,542 USD
68,014 -7.9% 0.14 9,542 USD
2022-12-01 2022-11-29 B Purchase

Postma Robert W

Non-Executive Director
750,000 +17.6%
0.65
487,500 USD
750,000 +17.6% 0.65 487,500 USD
2022-12-01 2022-11-29 B Purchase

Vieser Jaime

Non-Executive Director
1,250,000 +inf%
0.65
812,500 USD
1,250,000 +inf% 0.65 812,500 USD
2021-11-17 2021-11-17 B Purchase

Boyle Kevin S. Sr.

Chief Executive Officer

Executive Director
9,116 +1.0%
1.40
12,762 USD
9,116 +1.0% 1.40 12,762 USD
2021-11-17 2021-11-16 B Purchase

Boyle Kevin S. Sr.

Chief Executive Officer

Executive Director
884 +0.1%
1.40
1,238 USD
884 +0.1% 1.40 1,238 USD
2021-10-04 2021-09-29 B Purchase

Vieser Jaime

Non-Executive Director
100,000 +16.5%
1.91
191,000 USD
100,000 +16.5% 1.91 191,000 USD
2021-09-03 2021-09-02 B Purchase

Postma Robert W

Non-Executive Director
54,492 +1.3%
1.73
94,271 USD
54,492 +1.3% 1.73 94,271 USD
2021-09-03 2021-09-02 B Purchase

Postma Robert W

Non-Executive Director
20,508 +1.7%
1.73
35,479 USD
20,508 +1.7% 1.73 35,479 USD
2021-01-12 2021-01-08 PS Planned sale

Buck Jill

EVP, GM Gene Therapy

Officer
27,894 -12.3%
3.12
87,029 USD
27,894 -12.3% 3.12 87,029 USD
2021-01-12 2021-01-08 PS Planned sale

Lafond Kevin G

SVP, Treasurer & CAO

Officer
18,020 -22.0%
3.09
55,682 USD
18,020 -22.0% 3.09 55,682 USD
2021-01-12 2021-01-08 PS Planned sale

Hadfield Robert

General Counsel and Secretary

Officer
26,500 -16.6%
3.12
82,680 USD
26,500 -16.6% 3.12 82,680 USD
2021-01-06 2021-01-04 PS Planned sale

De Groot Eleanor

EVP, GM Cell Therapy

Officer
21,620 -9.5%
2.72
58,806 USD
21,620 -9.5% 2.72 58,806 USD
2021-01-06 2021-01-04 PS Planned sale

Cooper Laurence James Neil

President and CEO

Executive Director
105,693 -5.5%
2.71
286,428 USD
105,693 -5.5% 2.71 286,428 USD
2020-01-03 2020-01-02 PS Planned sale

MAUNEY DAVID M MD

President

Officer
22,394 -10.3%
4.55
101,893 USD
22,394 -10.3% 4.55 101,893 USD
2020-01-03 2020-01-02 PS Planned sale

Buck Jill

EVP, GM Gene Therapy

Officer
27,923 -13.8%
4.55
127,050 USD
27,923 -13.8% 4.55 127,050 USD
2020-01-03 2020-01-02 PS Planned sale

De Groot Eleanor

EVP, GM Cell Therapy

Officer
24,890 -12.5%
4.55
113,250 USD
24,890 -12.5% 4.55 113,250 USD
2020-01-03 2020-01-02 PS Planned sale

Hadfield Robert

General Counsel and Secretary

Officer
16,853 -14.3%
4.55
76,681 USD
16,853 -14.3% 4.55 76,681 USD
2020-01-03 2020-01-02 PS Planned sale

Lafond Kevin G

SVP, Treasurer & CAO

Officer
21,570 -25.2%
4.55
98,144 USD
21,570 -25.2% 4.55 98,144 USD
2019-12-31 2019-12-30 PS Planned sale

Cooper Laurence James Neil

Chief Executive Officer

Executive Director
110,694 -6.0%
4.88
540,187 USD
110,694 -6.0% 4.88 540,187 USD
2019-11-27 2019-11-26 PS Planned sale

Lafond Kevin G

SVP, Treasurer & CAO

11,667 -12.0%
5.25
61,252 USD
11,667 -12.0% 5.25 61,252 USD
2017-11-09 2017-11-08 B Purchase

Cooper Laurence James Neil

Chief Executive Officer

6,440 +0.6%
4.68
30,139 USD
6,440 +0.6% 4.68 30,139 USD
2017-11-09 2017-11-08 B Purchase

MAUNEY DAVID M MD

EVP and Chief Business Officer

4,270 +7.9%
4.68
19,984 USD
4,270 +7.9% 4.68 19,984 USD
2015-11-23 2015-11-19 S Sale

BELBEL CAESAR J

COO, CLO, and Secretary

Officer
153,333 -72.1%
12.84
1,968,796 USD
153,333 -72.1% 12.84 1,968,796 USD
2015-06-11 2015-06-09 S Sale

LEBEL FRANCOIS

Executive Vice President R&D

Officer
50,000 -100.0%
10.12
506,000 USD
50,000 -100.0% 10.12 506,000 USD
2015-06-05 2015-06-04 S Sale

BRENNAN MURRAY

Non-Executive Director
5,837 -31.8%
9.55
55,743 USD
5,837 -31.8% 9.55 55,743 USD
2015-06-05 2015-06-03 S Sale

Lafond Kevin G

Vice Pres., Treasurer, & CAO

Officer
27,500 -100.0%
9.70
266,750 USD
27,500 -100.0% 9.70 266,750 USD
2015-06-05 2015-06-03 S Sale

Lafond Kevin G

Vice Pres., Treasurer, & CAO

Officer
3,334 -100.0%
9.70
32,340 USD
3,334 -100.0% 9.70 32,340 USD
2015-06-05 2015-06-03 S Sale

BRENNAN MURRAY

Non-Executive Director
34,163 -65.1%
9.72
332,064 USD
34,163 -65.1% 9.72 332,064 USD
2015-06-05 2015-06-03 S Sale

Lafond Kevin G

Vice Pres., Treasurer, & CAO

Officer
26,666 -100.0%
9.60
255,994 USD
26,666 -100.0% 9.60 255,994 USD
2015-02-10 2015-02-09 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
1,440,000 +8.8%
8.75
12,600,000 USD
1,440,000 +8.8% 8.75 12,600,000 USD
2013-10-31 2013-10-29 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
2,857,143 +21.1%
3.50
10,000,001 USD
2,857,143 +21.1% 3.50 10,000,001 USD
2012-01-23 2012-01-20 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
1,923,075 +24.1%
5.20
9,999,990 USD
1,923,075 +24.1% 5.20 9,999,990 USD
2011-08-25 2011-08-23 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
38,294 +2.9%
4.99
191,087 USD
38,294 +2.9% 4.99 191,087 USD
2011-08-22 2011-08-22 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
110,792 +9.3%
4.91
543,989 USD
110,792 +9.3% 4.91 543,989 USD
2011-08-22 2011-08-19 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
197,376 +19.7%
4.91
969,116 USD
197,376 +19.7% 4.91 969,116 USD
2011-08-22 2011-08-18 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
153,478 +18.1%
4.95
759,716 USD
153,478 +18.1% 4.95 759,716 USD
2011-08-11 2011-08-10 B Purchase

Fowler Wyche

Non-Executive Director
5,000 +7.4%
5.19
25,926 USD
5,000 +7.4% 5.19 25,926 USD
2011-08-09 2011-08-09 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
285,518 +50.9%
5.13
1,464,707 USD
285,518 +50.9% 5.13 1,464,707 USD
2011-08-09 2011-08-08 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
444,892 +383.2%
4.58
2,037,605 USD
444,892 +383.2% 4.58 2,037,605 USD
2011-08-09 2011-08-05 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
116,112 +inf%
4.65
539,921 USD
116,112 +inf% 4.65 539,921 USD
2011-02-07 2011-02-03 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
1,910,000 +31.5%
5.75
10,982,500 USD
1,910,000 +31.5% 5.75 10,982,500 USD
2011-01-14 2011-01-12 B Purchase

KIRK RANDAL J

Non-Executive Director Large shareholder
2,426,235 +inf%
4.80
11,645,928 USD
2,426,235 +inf% 4.80 11,645,928 USD
2009-12-11 2009-12-09 B Purchase

MCINERNEY TIMOTHY

Non-Executive Director
50,000 +31.6%
3.10
155,000 USD
50,000 +31.6% 3.10 155,000 USD
2009-12-11 2009-12-09 B Purchase

CANNON JAMES ANTHONY

Non-Executive Director
175,000 +388.9%
3.10
542,500 USD
175,000 +388.9% 3.10 542,500 USD
2009-12-10 2009-12-08 B Purchase

ESSEX WOODLANDS HEALTH VENTURES FUND VI L P

Large shareholder
129,000 +5.8%
3.10
399,900 USD
129,000 +5.8% 3.10 399,900 USD
2009-12-10 2009-09-15 B Purchase

ESSEX WOODLANDS HEALTH VENTURES FUND VI L P

Large shareholder
328,766 +17.2%
1.83
599,998 USD
328,766 +17.2% 1.83 599,998 USD
2009-09-17 2009-09-15 B Purchase

MCINERNEY TIMOTHY

Non-Executive Director
50,000 +63.9%
1.83
91,250 USD
50,000 +63.9% 1.83 91,250 USD
2007-12-10 2007-12-07 B Purchase

LEWIS JONATHAN

CEO

Executive Director
3,000 +150.0%
3.00
8,990 USD
3,000 +150.0% 3.00 8,990 USD
2007-03-22 2007-03-15 B Purchase

MCINERNEY TIMOTHY

Non-Executive Director
4,000 +6.8%
5.00
20,000 USD
4,000 +6.8% 5.00 20,000 USD
2007-03-14 2007-03-12 B Purchase

LEWIS JONATHAN

CEO

Executive Director
2,000 +inf%
4.95
9,900 USD
2,000 +inf% 4.95 9,900 USD